Thiazolidinedione analogues for the treatment of metabolic diseases
The present invention relates to thiazolidinedione analogues that are useful for treating hypertension, diabetes, and inflammatory diseases. Formula (I), wherein: each of R 1 and R 4 is independently selected from H, halo, aliphatic, and alkoxy, wherein the aliphatic and alkoxy are optionally substituted with 1-3 of halo; R 2 is halo, hydroxy, or optionally substituted aliphatic, and R′ 2 is H, or R 2 and R′ 2 together form oxo; R 3 is H; and Ring A is a phenyl.
1. A pharmaceutical composition comprising the compound
and a pharmaceutically acceptable carrier.
2. The pharmaceutical composition of claim 1 , further comprising a diuretic selected from hydrochlorothiazide, chlorothaladone, chlorothiazide, or any combination thereof; a statin selected from atorvastatin, cerivastatin, fluvastatin, lovastatin, mevastatin, simvastatin, rosuvastatin, pravastatin, or any combination thereof; an angiotension II receptor blocker selected from losartan, olmesartan, telmisartan, or any combination thereof; an ACE inhibitor selected from ramipril, captopril, enalapril, or any combination thereof; calcium channel blocker selected from amlodipine; or combination thereof.
3. The pharmaceutical composition of claim 1 , further comprising a glucocorticoid agonist selected from cortisone, hydrocortisone, predisone, prednisolone, methylprednisolone, betamethasone, triamcinolone, or any combination thereof.
4. A compound selected from:
5-(4-(2-(3-methoxyphenyl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione.